HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancer

por Abdel-Fatah, T M A, McArdle, S E B, Johnson, C, Moseley, P M, Ball, G R, Pockley, A G, Ellis, I O, Rees, R C, Chan, S Y T
Publicado 2014